Mumps outbreak in vaccinated children in Gipuzkoa (Basque Country), Spain

Epidemiology and Infection

Volumn 129, Issue 3, 2002, Pages 551-556

  Montes, M ^a   Cilla, G ^a   Artieda, J ^b   Vicente, D ^a   Basterretxea, M ^b  

^a HOSPITAL DONOSTIA   (Spain)

^b Unidad de Epidemiología   (Spain)

Author keywords

[No Author keywords available]

Indexed keywords

IMMUNOGLOBULIN M; MEASLES MUMPS RUBELLA VACCINE; VIRUS RNA;

ADOLESCENT; ADULT; AGE; ANTIBODY SPECIFICITY; CHILD; CONTROLLED STUDY; EPIDEMIC; FEMALE; FREQUENCY ANALYSIS; GENE SEQUENCE; GENOTYPE; HEALTH PROGRAM; HUMAN; HYDROPHOBICITY; MAJOR CLINICAL STUDY; MALE; MEASLES; MUMPS; MUMPS VIRUS; NONHUMAN; REVACCINATION; REVIEW; RUBELLA; SEQUENCE ANALYSIS; SPAIN; STRAIN DIFFERENCE; TIME; VACCINATION; VIRUS CULTURE; VIRUS DETECTION; VIRUS STRAIN; WILD TYPE;

CHILD, PRESCHOOL; DISEASE OUTBREAKS; DNA, VIRAL; FEMALE; HUMANS; IMMUNOGLOBULIN M; INCIDENCE; MALE; MEASLES-MUMPS-RUBELLA VACCINE; MUMPS; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, VIRAL; SPAIN;

EID: 0036973254     PISSN: 09502688     EISSN: None     Source Type: Journal    
DOI: 10.1017/S095026880200763X     Document Type: Review

References (29)

1. Carbone KM, Wolinsky JS. Mumps virus. In: Knipe DM, Howley PM, Griffin DE, Lamb RA, Martin MA, Roizman B, Straus SE, eds. Fields virology, 4th ed. Philadelphia, USA: Lippincott-Williams & Wilkins, 2001: 1381-400.
2. Galazka AM, Robertson SE, Kraigher A. Mumps and mumps vaccine: a global review. Bull WHO 1999; 77: 3-14.
3. Peltola H, Davidkin I, Paunio M, Valle M, Leinikki P, Heinonen OP. Mumps and rubella eliminated from Finland. JAMA 2000; 284: 2643-7.
4. Wharton M, Cochi SL, Hutcheson RH, Bistowish JM, Schaffner W. A large outbreak of mumps in the postvaccine era. J Infect Dis 1988; 158: 1253-60.
5. Dias JA, Cordeiro M, Afkal MA, et al. Mumps epidemic in Portugal despite high vaccine coverage-preliminary report. Eurosurveillance 1996; 1: 25-8.
6. Dirección de Salud de Gipuzkoa. Enfermedades Notificadas al Sistema EDO en el año 1999. Memoria del año 1999 de la Unidad de Epidemiología e Información. Departamento de Sanidad. Gobierno Vasco, San Sebastián, 2000.
7. Germann D, Gorgievski M, Ströhle A, Matter L. Detection of mumps virus in clinical specimens by rapid centrifugation culture and conventional tube cell culture. J Virol Meth 1998; 73: 59-64.
8. Wu L, Bai Z, Li Y, Rima BK, Afkal MA. Wild type mumps viruses circulating in China establish a new genotype. Vaccine 1998; 16: 281-5.
9. Pachón I, Tormo A. Situación de la parotiditis en España durante 1996. Bol Epidemiol Sem 1997; 5: 13-6.
10. Amela C, Pachón I, Alvarez E, Sanz C. Sarampión, rubéola y parotiditis: situación actual. Bol Epidemiol Sem 2000; 8: 229-33.
11. Instituto de Salud Carlos III. Comentario Epidemiológico de las Enfermedades de Declaración Obligatoria y Sistema de Información Microbiológico. España año 2000. Bol Epidemiol Sem 2001; 9: 101-7.
12. Pons C, Pelayo T, Pachón I, et al. Two outbreaks of mumps in children vaccinated with the Rubini strain in Spain indicate low vaccine efficacy. Eurosurveillance 2000; 5: 80-4.
13. De los Ríos R, García Marin N, Sanz Moreno JC, Ballester E. Parotiditis en un área urbana de la Comunidad de Madrid. Estado vacunal, diagnóstico y medidas de intervención. Atención Primaria 2001; 28: 10-6.
14. Schlegel M, Osterwalder JJ, Galeazzi RL, Vernazza PL. Comparative efficacy of three mumps vaccines during disease outbreak in eastern Switzerland: cohort study. BMJ 1999; 319: 352-3.
15. Germann D, Ströhle A, Eggenberger K, Steiner CA, Matter L. An outbreak of mumps in a population partially vaccinated with the Rubini strain. Scand J Infect Dis 1996; 28: 235-8.
16. The Benevento and Compobasso Pediatricians Network for the control of Vaccine-Preventable Diseases. Field evaluation of the clinical effectiveness of vaccines against pertussis, measles, rubella and mumps. Vaccine 1998; 16: 818-22.
17. Cusi MG, Bianchi S, Valassina M, Santini L, Arnetoli M, Valensin PE. Rapid detection and typing of circulating mumps virus by reverse transcription/polymerase chain reaction. Res Virol 1996; 147: 227-32.
18. Afzal MA, Buchanan J, Heath AB, Minor PD. Clustering of mumps virus isolates by SH gene sequence only partially reflects geographical origin. Arch Virol 1997; 142: 227-38.
19. Örvell C, Kalantari M, Johansson B. Characterization of five conserved genotypes of the mumps virus small hydrophobic (SH) protein gene. J Gen Virol 1997; 78: 91-5.
20. Tecle, T, Johansson B, Jejcic A, Forsgren M, Örvell C. Characterization of three co-circulating genotypes of the small hydrophobic protein gene of mumps virus. J Gen Virol 1998; 79: 2929-37.
21. Jin L, Beard S, Brown DWG. Genetic heterogeneity of mumps virus in the United Kingdom: identification of two new genotypes. J Infect Dis 1999; 180: 829-33.
22. Kim SH, Song K-J, Shin YK, et al. Phylogenefic analysis of the small hydrophobic (SH) gene of mumps virus in Korea: identification of a new genotype. Microbiol Immunol 2000; 44: 173-7.
23. Tecle T, Böttiger B, Örvell C, Johansson B. Characterization of two decades of temporal co-circulation of four mumps virus genotypes in Denmark: identification of a new genotype. J Gen Virol 2001; 82: 2675-80.
24. Ströhle A, Bernasconi C, Germann D. A new mumps virus lineage found in the 1995 mumps outbreak in Western Switzerland identified by nucleotide sequence analysis of the SH gene. Arch Virol 1996; 141: 733-41.
25. Aftal MA, Buchanan J, Dias JA, et al. RT-PCR based diagnosis and molecular characterisation of mumps viruses derived from clinical specimens collected during the 1996 mumps outbreak in Portugal. J Med Virol 1997; 52: 349-53.
26. Takahashi M, Nakayama T, Kashiwagi Y, et al. Single genotype of measles virus is dominant whereas several genotypes of mumps virus are co-circulating. J Med Virol 2000; 62: 278-85.
27. Cohen BJ, Jin L, Brown DW, Kitson M. Infection with wild-type mumps virus in army recruits temporally associated with MMR vaccine. Epidemiol Infect 1999; 123: 251-5.
28. Nöjdt J, Tecle T, Samuelsson A, Örvell C. Mumps virus neutralizing antibodies do not protect against reinfection with a heterologous mumps virus genotype. Vaccine 2001; 19: 1727-31.
29. Gut J-P, Lablache Ch, Behr S, Jirn A. Symptomatic mumps virus reinfections. J Med Virol 1995; 45: 17-23.